Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer

Nutrition and Cancer

Volumn 66, Issue 4, 2014, Pages 716-727

  Kantor, Elizabeth D ^a   Lampe, Johanna W ^b   Peters, Ulrike ^b   Vaughan, Thomas L ^b   White, Emily ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENETIC ASSOCIATION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; ANALYSIS; ANIMAL; COLORECTAL NEOPLASMS; FISH; INCIDENCE; LIFESTYLE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEA FOOD; UNITED STATES;

AGED; ANIMALS; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; FISHES; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEAFOOD; WASHINGTON;

EID: 84899915981     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.804101     Document Type: Article

References (44)

1. Jemal A, Siegel R, Xu J, and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60, 277-300, 2010.
2. Cai Q, Gao YT, Chow WH, Shu XO, Yang G, et al.: Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 24, 5010-5016, 2006.
3. Schottenfeld D and Beebe-Dimmer J: Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56(2), 69-83, 2006.
4. Ebrahimi M, Ghayour-Mobarhan M, Rezaiean S, HoseiniM, Parizade SM, et al.: Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity. Acta Cardiol 64, 321-327, 2009.
5. Micallef MA and Garg ML: Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476-482, 2009.
6. Latham P, Lund EK, and Johnson IT: Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20, 645-650, 1999.
7. Clarke RG, Lund EK, Latham P, Pinder AC, and Johnson IT: Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids 34, 1287-1295, 1999.
8. Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, et al.: Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 22, 765-776, 2007.
9. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, et al.: n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25, 2303-2310, 2004.
10. Wu S, Feng B, Li K, Zhu X, Liang S, et al.: Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med 125, 551-9.e5, 2012.
11. Geelen A, Schouten JM, Kamphuis C, Stam BE, Burema J, et al.: Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol 166, 1116-1125, 2007.
12. MacLean CH, Newberry SJ,Mojica WA, Khanna P, Issa AM, et al.: Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403-415, 2006.
13. Gerber M: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107(Suppl 2), S228-S239, 2012.
14. Wu CH,Wang CC, and Kennedy J: Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 33, 1749-1758, 2011.
15. Satia JA, Littman A, Slatore CG, Galanko JA, and White E: Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev 18, 1419-1428, 2009.
16. White E, Patterson RE, Kristal AR, Thornquist M, King I, et al.: VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol. 159(1):83-93, 2004.
17. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, et al.: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9, 178-187, 1999.
18. Kristal AR, Brasky TM, Lampe JE, Patterson RE, and White E: Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Manuscript under review.
19. Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, and Severson RK: Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127, 942-951, 2010.
20. He J, Wilkens LR, Stram DO, Kolonel LN, Henderson BE, et al.: Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 20, 70-81, 2011.
21. Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, et al.: Metaanalysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 42, 973-977, 2010.
22. Slattery ML, Lundgreen A, Herrick JS, Wolff RK, and Caan BJ: Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117, 4175-4183, 2011.
23. Lubbe SJ,Whiffin N, Chandler I, Broderick P, and Houlston RS: Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients. Carcinogenesis 33, 108-112, 2012.
24. Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A: Dietary longchain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935-945, 2004.
25. Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al.: Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181-195, 2007.
26. Hall MN, Campos H, Li H, Sesso HD, Stampfer MJ, et al.: Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 314-321, 2007.
27. Kojima M, Wakai K, Tokudome S, Suzuki K, Tamakoshi K, et al.: Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study. Am J Epidemiol 161, 462-471, 2005.
28. Sasazuki S, Inoue M, IwasakiM, Sawada N, Shimazu T, et al. Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan public health center-based prospective study. Int J Cancer 129, 1718-1729, 2011.
29. Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, et al.: Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 124, 678-686, 2009.
30. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, et al.: Longterm effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741-1750, 2010.
31. Botma A, Nagengast FM, Braem MG, Hendriks JC, Kleibeuker JH, et al.: Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28, 4346-4353, 2010.
32. Heine-Bröring RC,Winkels RM, Botma A, van Duijnhoven FJB, Jung AY, et al.: Dietary supplement use and colorectal adenoma risk in individuals with Lynch Syndrome: TheGEOLynch Cohort Study. PloS ONE 8, e66819, 2013.
33. SternMC, Butler LM, Corral R, Joshi AD, Yuan JM, et al.: Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study. J Nutrigenet Nutrigenomics 2, 273-279, 2009.
34. Habermann N, Ulrich CM, Lundgreen A, Makar KW, Poole EM, et al.: PTGS1, PTGS2,ALOX5,ALOX12,ALOX15, and FLAPSNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr 8, 115-126, 2012.
35. Poole EM, Bigler J, Whitton J, Sibert JG, Kulmacz RJ, et al.: Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. Carcinogenesis 28, 1259-1263, 2007.
36. Mollard RC, Gillam ME,Wood TM, Taylor CG, and Weiler HA: (n-3) fatty acids reduce the release of prostaglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J Nutr 135, 499-504, 2005.
37. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, et al.: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30, 2006.
38. Fritsche K: Fatty acids as modulators of the immune response. Annu Rev Nutr 26, 45-73, 2006.
39. Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, et al.: Association between use of specialty dietary supplements and C-reactive protein concentrations. American Journal of Epidemiology 176, 1002-1013, 2012.
40. Chapkin RS, Kim W, Lupton JR, and McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81, 187-191, 2009.
41. Wall R, Ross RP, Fitzgerald GF, and Stanton C: Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68, 280-289, 2010.
42. Zhao Y, Joshi-Barve S, Barve S, and Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23, 71-78, 2004.
43. Li Q, Withoff S, and Verma IM: Inflammation-associated cancer: NFkappaB is the lynchpin. Trends Immunol 26, 318-325, 2005.
44. Chang WL, Chapkin RS, and Lupton JR: Fish oil blocks azoxymethaneinduced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr 128, 491-497, 1998.